Search Result

Results for "

TRAF1

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Akt (2) Apoptosis (2) ASK1 (2) Keap1-Nrf2 (2) Small Interfering RNA (siRNA) (3)
By Research Areas:	Neurological Disease (2)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

Inhibitors & Agonists

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

Aceglutamide α-N-Acetyl-L-glutamine; N2-Acetylglutamine	Keap1-Nrf2 Akt ASK1 Apoptosis	Neurological Disease
Aceglutamide (α-N-Acetyl-L-glutamine; N2-Acetylglutamine) is a neuroprotectant that can penetrate the blood-brain barrier. Aceglutamide can enhance the antioxidant systems of glutathione (GSH), thioredoxin (Trx) and Nrf2. Aceglutamide also inhibits *ASK1* and *TRAF1, activates the Akt/Bcl-2* anti-apoptotic pathway, enhances the activity of antioxidant enzymes and reduces oxidative damage. Aceglutamide can improve neurological deficits after cerebral ischemia, reduce infarct volume, and inhibit neuronal apoptosis, especially substantia nigra dopaminergic neurons. Aceglutamide can reduce cerebral ischemia/reperfusion injury, improve motor dysfunction, and is used in ischemic stroke-related research ^[1] .

Traf1 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Traf1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Traf1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Traf1 Mouse Pre-designed siRNA Set A Traf1 Mouse Pre-designed siRNA Set A

Traf1 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Traf1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Traf1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Traf1 Rat Pre-designed siRNA Set A Traf1 Rat Pre-designed siRNA Set A

TRAF1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
TRAF1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAF1 Human Pre-designed siRNA Set A TRAF1 Human Pre-designed siRNA Set A

Aceglutamide (Standard) α-N-Acetyl-L-glutamine (Standard); N2-Acetylglutamine (Standard)	Keap1-Nrf2 Akt ASK1 Apoptosis	Neurological Disease
Aceglutamide (α-N-Acetyl-L-glutamine; N2-Acetylglutamine) (Standard) is the analytical standard of Aceglutamide (HY-B1065). This product is intended for research and analytical applications. Aceglutamide (α-N-Acetyl-L-glutamine; N2-Acetylglutamine) is a neuroprotectant that can penetrate the blood-brain barrier. Aceglutamide can enhance the antioxidant systems of glutathione (GSH), thioredoxin (Trx) and Nrf2. Aceglutamide also inhibits *ASK1* and *TRAF1, activates the Akt/Bcl-2* anti-apoptotic pathway, enhances the activity of antioxidant enzymes and reduces oxidative damage. Aceglutamide can improve neurological deficits after cerebral ischemia, reduce infarct volume, and inhibit neuronal apoptosis, especially substantia nigra dopaminergic neurons. Aceglutamide can reduce cerebral ischemia/reperfusion injury, improve motor dysfunction, and is used in ischemic stroke-related research ^[1] .

Cat. No.	Product Name	Category	Target	Chemical Structure

Aceglutamide α-N-Acetyl-L-glutamine; N2-Acetylglutamine	Structural Classification Microorganisms Ketones, Aldehydes, Acids Source classification Endogenous metabolite	Keap1-Nrf2 Akt ASK1 Apoptosis
Aceglutamide (α-N-Acetyl-L-glutamine; N2-Acetylglutamine) is a neuroprotectant that can penetrate the blood-brain barrier. Aceglutamide can enhance the antioxidant systems of glutathione (GSH), thioredoxin (Trx) and Nrf2. Aceglutamide also inhibits *ASK1* and *TRAF1, activates the Akt/Bcl-2* anti-apoptotic pathway, enhances the activity of antioxidant enzymes and reduces oxidative damage. Aceglutamide can improve neurological deficits after cerebral ischemia, reduce infarct volume, and inhibit neuronal apoptosis, especially substantia nigra dopaminergic neurons. Aceglutamide can reduce cerebral ischemia/reperfusion injury, improve motor dysfunction, and is used in ischemic stroke-related research ^[1] .

Aceglutamide (Standard) α-N-Acetyl-L-glutamine (Standard); N2-Acetylglutamine (Standard)	Structural Classification Microorganisms Ketones, Aldehydes, Acids Source classification Endogenous metabolite	Keap1-Nrf2 Akt ASK1 Apoptosis
Aceglutamide (α-N-Acetyl-L-glutamine; N2-Acetylglutamine) (Standard) is the analytical standard of Aceglutamide (HY-B1065). This product is intended for research and analytical applications. Aceglutamide (α-N-Acetyl-L-glutamine; N2-Acetylglutamine) is a neuroprotectant that can penetrate the blood-brain barrier. Aceglutamide can enhance the antioxidant systems of glutathione (GSH), thioredoxin (Trx) and Nrf2. Aceglutamide also inhibits *ASK1* and *TRAF1, activates the Akt/Bcl-2* anti-apoptotic pathway, enhances the activity of antioxidant enzymes and reduces oxidative damage. Aceglutamide can improve neurological deficits after cerebral ischemia, reduce infarct volume, and inhibit neuronal apoptosis, especially substantia nigra dopaminergic neurons. Aceglutamide can reduce cerebral ischemia/reperfusion injury, improve motor dysfunction, and is used in ischemic stroke-related research ^[1] .

Cat. No.	Compare	Product Name	Species	Source

	TRAF1 Protein, Human (sf9, GST) EBI6	Human	Sf9 insect cells
	TRAF1 Protein, Human (sf9, GST) is the recombinant human-derived TRAF1, expressed by Sf9 insect cells , with GST labeled tag. ,

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Traf1 Mouse Pre-designed siRNA Set A		siRNAs Mouse Pre-designed siRNA Sets
Traf1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Traf1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Traf1 Rat Pre-designed siRNA Set A		siRNAs Rat Pre-designed siRNA Sets
Traf1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Traf1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAF1 Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
TRAF1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Name
Email *

	Sorry, but the email address you supplied was invalid.